Evaluation of the Atlas Genetics io® CTNG System
NCT03071510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7128
Last updated 2020-04-03
Summary
Atlas Genetics io® system results are compared with those obtained from comparator devices.
Conditions
- Chlamydia Trachomatis
- Gonorrhea
Interventions
- DEVICE
-
Atlas Genetics io® system
Specimen Collection
Sponsors & Collaborators
-
Binx Health Limited
lead INDUSTRY
Principal Investigators
-
Barbara Van der Pol, PhD · University of Alabama at Birmingham
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-18
- Primary Completion
- 2019-08-30
- Completion
- 2019-08-30
Countries
- United States
Study Locations
More Related Trials
-
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
NCT01638637 ·Status: COMPLETED
-
Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs
NCT03596151 ·Status: TERMINATED ·Phase: NA
-
Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples
NCT02795975 ·Status: TERMINATED
-
Identigene STD Test Collection Kit Validation Study
NCT01471392 ·Status: UNKNOWN ·Phase: PHASE3
-
Self-taken Penile Meatal Swabs for Chlamydia, Gonorrhoea and Mycoplasma Genitalium Detection
NCT04244994 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of the ID NOW™ CT/NG Test
NCT06395675 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
NCT00252096 ·Status: COMPLETED ·Phase: NA
-
Cepheid Rectal Sample Validation Study
NCT02099760 ·Status: COMPLETED
-
A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections
NCT06369220 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System
NCT01733069 ·Status: COMPLETED
-
Point of Care Rapid STI Test Optimization and Validation Extension
NCT06566677 ·Status: COMPLETED
-
Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System
NCT01358799 ·Status: WITHDRAWN
-
Clinical Evaluation of the Click Sexual Health Test for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) in Women
NCT04098900 ·Status: COMPLETED
-
Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing
NCT01849653 ·Status: COMPLETED
-
A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients
NCT03037957 ·Status: COMPLETED
-
Pharmacy-based Testing and Treatment for Gonorrhea and Chlamydia
NCT06234943 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SYSTEMATIC: NAATS of Pooled Selftaken Versus Clinicantaken Swabs 1
NCT02371109 ·Status: COMPLETED
-
Rapid Diagnostic Assay for Gonorrhea and Chlamydia
NCT05564299 ·Status: COMPLETED ·Phase: NA
-
Incubation Time and Test of Cure of Chlamydia Trachomatis
NCT01448876 ·Status: COMPLETED
-
Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe
NCT05541081 ·Status: COMPLETED ·Phase: NA
-
Adolescent Sexually Transmitted Infection Screening in the Emergency Department
NCT03715335 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing
NCT00978848 ·Status: COMPLETED
-
Aztreonam for Pharyngeal Gonorrhea
NCT03867734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
NCT00115388 ·Status: COMPLETED ·Phase: NA
-
Mycoplasma Genitalium Infection and Associated Antimicrobial Resistance Among HIV-infected Male in Hong Kong
NCT05789134 ·Status: COMPLETED